mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection

Ellie N. Ivanova, Jasmine Shwetar, Joseph C. Devlin, Terkild B. Buus, Sophie Gray-Gaillard, Akiko Koide, Amber Cornelius, Marie I. Samanovic, Alberto Herrera, Eleni P. Mimitou, Chenzhen Zhang, Trishala Karmacharya, Ludovic Desvignes, Niels Ødum, Peter Smibert, Robert J. Ulrich, Mark J. Mulligan, Shohei Koide, Kelly V. Ruggles, Ramin S. Herati, Sergei B. Koralov

Abstract

SARS-CoV-2 infection and vaccination elicit potent immune responses. Our study presents a comprehensive multimodal single-cell analysis of blood from COVID-19 patients and healthy volunteers receiving the SARS-CoV-2 vaccine and booster. We profiled immune responses via transcriptional analysis and lymphocyte repertoire reconstruction. COVID-19 patients displayed an enhanced interferon signature and cytotoxic gene upregulation, absent in vaccine recipients. B and T cell repertoire analysis revealed clonal expansion among effector cells in COVID-19 patients and memory cells in vaccine recipients. Furthermore, while clonal αβ T cell responses were observed in both COVID-19 patients and vaccine recipients, expansion of clonal γδ T cells was found only in infected individuals. Our dataset enables side-by-side comparison of immune responses to infection versus vaccination, including clonal B and T cell responses. Our comparative analysis shows that vaccination induces a robust, durable clonal B and T cell responses, without the severe inflammation associated with infection.

Datasets

1. Circulating Immune cells -- CV19 infection, vaccination and HC
Metadata
BCR_IGH.V.1
BCR_IGH.D.1
BCR_IGH.J.1
BCR_IGH.C.1
BCR_IGL.V.1
BCR_IGL.J.1
BCR_IGL.C.1
BCR_IGK.V.1
BCR_IGK.J.1
BCR_IGK.C.1
TCRab_TRA.V.1
TCRab_TRA.J.1
TCRab_TRA.C.1
TCRab_TRB.V.1
TCRab_TRB.D.1
TCRab_TRB.J.1
TCRab_TRB.C.1
TCRab.top10
TCRgd_TRD.V.1
TCRgd_TRD.J.1
TCRgd_TRD.C.1
TCRgd_TRG.V.1
TCRgd_TRG.J.1
TCRgd_TRG.C.1
Day
DayFactor
assay_ontology_term_id
development_stage_ontology_term_id
disease_ontology_term_id
donor_id
organism_ontology_term_id
self_reported_ethnicity_ontology_term_id
sex_ontology_term_id
suspension_type
tissue_ontology_term_id
age_group
celltype.final
cell_type_ontology_term_id
celltype.broad_clustering_annot
library_prep_batch
sampleName_with_day
cv19_vax_boost_or_HC_status
tissue_type
cell_type
assay
disease
organism
sex
tissue
self_reported_ethnicity
development_stage
NA177095 cells
IGHV3-231585 cells
IGHV3-331522 cells
IGHV4-391029 cells
IGHV4-341020 cells
IGHV1-69D960 cells
IGHV4-59919 cells
IGHV3-21797 cells
IGHV3-30789 cells
IGHV1-18710 cells
IGHV3-7677 cells
IGHV3-48630 cells
IGHV3-43592 cells
IGHV1-2592 cells
IGHV4-30-4570 cells
IGHV3-15488 cells
IGHV5-51467 cells
IGHV3-11426 cells
IGHV1-46407 cells
IGHV2-5405 cells
IGHV4-61356 cells
IGHV3-74330 cells
IGHV1-8303 cells
IGHV3-53297 cells
IGHV1-3279 cells
IGHV7-4-1226 cells
IGHV3-49220 cells
IGHV1-24186 cells
IGHV4-4182 cells
IGHV5-10-1172 cells
IGHV2-70163 cells
IGHV2-26152 cells
IGHV3-66134 cells
IGHV6-1132 cells
IGHV4-38-2130 cells
IGHV3-20117 cells
IGHV4-3190 cells
IGHV3-7388 cells
IGHV3-1373 cells
IGHV1-5869 cells
IGHV3-64D58 cells
IGHV3-7254 cells
IGHV3-6442 cells
IGHV4-30-234 cells
IGHV1-6920 cells
IGHV4-289 cells
IGHV1-69-28 cells
IGHV3/OR16-127 cells
IGHV2-70D6 cells
IGHV1/OR15-14 cells
IGHV1-454 cells
IGHV3/OR16-82 cells
IGHV7-811 cells
IGHV3/OR16-131 cells
IGHV3-351 cells
IGHV3-161 cells
IGHV3/OR16-101 cells
Preview
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection

Analyze this study

Source data

https://cellxgene.cziscience.com/collections/ecb739c5-fe0d-4b48-81c6-217c4d64eec4

Alias names

GSE247917, PMID38213787, PMC10783604

Cite this study

Ivanova, E.N., Shwetar, J., Devlin, J.C., Buus, T.B., Gray-Gaillard, S., Koide, A., Cornelius, A., Samanovic, M.I., Herrera, A., Mimitou, E.P. and Zhang, C., 2023. mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection. Iscience, 26(12). https://doi.org/10.1016/j.isci.2023.108572